30 reports

Commonly used tests to check liver function are aspartate aminotransferase (AST), alanine transaminase (ALT), albumin, and bilirubin tests.

  • Digestive System Disorder
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.

THE CONDITION OF LIVER CAN BE DIAGNOSED BY METHODS SUCH AS, BLOOD TESTS, TISSUE ANALYSIS AND IMAGING TESTS.

  • Digestive System Disorder
  • World
  • Forecast
  • Market Size
  • Hitachi, Ltd.

Hepatitis virus COBAS HBV TEST ROCHE MOLECULAR SYSTEMS P## S##-S## ## WWW. WINTERGREENRESEARCH. COM/ BLOG VERSANT HCV RNA QUALITATIVE ASSAY GEN-PROBE, INC.

  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • Cepheid
  • PerkinElmer, Inc.

Hepatitis virus COBAS HBV TEST ROCHE MOLECULAR SYSTEMS P## S##-S## ## WWW. WINTERGREENRESEARCH. COM/ BLOG VERSANT HCV RNA QUALITATIVE ASSAY GEN-PROBE, INC.

  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • Cepheid
  • PerkinElmer, Inc.

The OraQuick HCV Rapid Antibody Test is the only CLIA-waived HCV test.

  • Antibiotic Resistance
  • Digestive System Disorder
  • Alere Inc.
  • Cepheid
  • Roche Group
  • Market trends

In Europe, Harvoni is used for the treatment of HCV genotype ## infection; HCV genotype ## infection associated with cirrhosis and prior treatment failure; and those with HIV- ##/ HCV co-infection.

  • Digestive System Disorder
  • Market Size
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Market trends

For instance, the US celebrates May ## as Hepatitis Testing Day each year and deemed May 2014 Hepatitis Awareness Month to raise awareness of hepatitis infections and encourage the testing of high-risk populations.

  • Antibiotic Resistance
  • Digestive System Disorder
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in France, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • France

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in France, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • France

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in UK, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium and

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • United Kingdom

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in UK, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium and

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • United Kingdom

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Italy, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Italy

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Italy, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium a

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Italy

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Germany, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, mediu

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Germany

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Germany, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Germany

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Spain, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Spain

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Spain, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium a

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Spain

THE NOVEL TEST DETECTS PLACENTAL ALPHA MICROGLOBULIN-## (PAMG-##) IN PATIENTS PRESENTING WITH SIGNS AND SYMPTOMS OF PRETERM LABOR.

  • Antibiotic Resistance
  • Infectious Disease
  • Medical Biotechnology
  • Tuberculosis
  • QIAGEN N.V.

HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) PRODUCT OVERVIEW HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage

  • Anti-Infective
  • Antibiotic Resistance
  • Monoclonal Antibody
  • Targeted Therapy
  • Roche Group
  • CLINICAL PCR AND OTHER NAAT MARKET, BY TYPE OF NAAT, WORLDWIDE, 2021

Assays that are currently available include CMV, HBV, HCV, and HIV-##.

  • Antibiotic Resistance
  • Biotech Diagnostics
  • Digestive System Disorder
  • Molecular Diagnostics
  • Biocartis S.A.

IN VITRO DIAGNOSTICS--> INFECTIOUS DIAGNOSTICS--> HEPATITIS TEST KITS--> HEPATITIS C TEST KITS CLASS III PMA RANDOM ACCESS SYSTEM - HCV GT ASSAY RANDOM ACCESS SYSTEM - HCV GT ASSAY PRODUCT OVERVIEW RANDOM ACCESS SYSTEM - HCV GT ASSAY - PROD

  • Antibiotic Resistance
  • Digestive System Disorder
  • In Vitro Diagnostics
  • Infectious Disease
  • Molecular Diagnostics

Harvoni was approved for pediatric patients with genotype ##, ##, ## or ## HCV infection.

  • Antibiotic Resistance
  • Digestive System Disorder
  • Lymphoma
  • United States
  • Gilead Sciences, Inc.
  • OCT 31, 2017: HEPQUANT MAKES CHANGE TO REGULATORY TEAM

" In cases of Alcoholic Hepatitis, tests like HepQuant SHUNT may be important because liver disease severity impacts short-term (weeks or months) survival.

  • Clinical Trial
  • Digestive System Disorder
  • Medical Device
  • United States
  • Product Initiative

CEPHEID OUTSIDE US IN APPROVAL PROCESS CLASS III As of May, 2018 GENEXPERT OMNI - HIV-## VIRAL LOAD TEST GENEXPERT OMNI - HIV-## VIRAL LOAD TEST PRODUCT OVERVIEW GENEXPERT OMNI - HIV-## VIRAL LOAD TEST - PRODUCT STATUS MARKET CATEGORY DEVELOPED BY P

  • Antibiotic Resistance
  • Infectious Disease
  • Point Of Care Testing
  • United States
  • Cepheid

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Cancer
  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.

Quidel Corp United States Early development Class II ##(k) September, 2023 SAVANNA - HCV ASSAY SAVANNA - HCV ASSAY PRODUCT OVERVIEW SAVANNA - HCV ASSAY - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage of Development Device Class Regulatory Pa

  • Antibiotic Resistance
  • Digestive System Disorder
  • Infectious Disease
  • United States
  • Quidel Corporation

IN VITRO DIAGNOSTICS--> INFECTIOUS DIAGNOSTICS--> HEPATITIS TEST KITS--> HEPATITIS C TEST KITS CLASS III PMA RANDOM ACCESS SYSTEM - HCV GT ASSAY RANDOM ACCESS SYSTEM - HCV GT ASSAY PRODUCT OVERVIEW RANDOM ACCESS SYSTEM - HCV GT ASSAY - PROD

  • Antibiotic Resistance
  • Digestive System Disorder
  • In Vitro Diagnostics
  • Infectious Disease
  • Molecular Diagnostics

The test group also included ## individuals with stable liver impairment, including individuals infected with HCV.

  • Digestive System Disorder
  • Liver Transplant
  • Transplantation
  • United States
  • Novartis AG

THUS, MOLECULAR HEPATITIS TESTS ARE OFTEN USED IN CONJUNCTION OR AS A FOLLOW-UP TO SEROLOGICAL HEPATITIS TESTS.

  • Antibiotic Resistance
  • Diagnostics
  • Digestive System Disorder
  • United States
  • World

Quidel Corp United States Early development Class II ##(k) September, 2023 SAVANNA - HCV ASSAY SAVANNA - HCV ASSAY PRODUCT OVERVIEW SAVANNA - HCV ASSAY - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage of Development Device Class Regulatory Pa

  • Antibiotic Resistance
  • Digestive System Disorder
  • Infectious Disease
  • United States
  • Quidel Corporation